Filing Details

Accession Number:
0001562180-20-005393
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-11 16:52:23
Reporting Period:
2020-08-07
Accepted Time:
2020-08-11 16:52:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503274 Quanterix Corp QTRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216068 E Marijn Dekkers C/O Quanterix Corporation,
900 Middlesex Turnpike
Billerica MA 01821
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-07 27,619 $32.49 0 No 4 S Indirect Held by Novalis LifeSciences Investments I, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Novalis LifeSciences Investments I, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,810 Direct
Footnotes
  1. Reflects the portion of 117,378 shares of the Issuer's common stock held by Novalis LifeSciences Investments I, L.P. (the "Fund") in which the Reporting Person had a pecuniary interest.
  2. This transaction was executed in multiple trades at prices ranging from $32.3489 to $32.5662. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The Reporting Person had sole voting and investment control over all of the shares owned by the Fund and had a pecuniary interest in 27,619 of the shares.
  4. Includes 2,270 restricted stock units.